Path ID: DB00153_MESH_D015663_1

Concepts
Identifier | Name | Type |
---|---|---|
DB:DB00153 | ergocalciferol | Drug |
CHEBI:86320 | 1α,25-dihydroxyvitamin D2 | ChemicalSubstance |
UniProt:P11473 | Vitamin D3 receptor | Protein |
GO:0070561 | vitamin D receptor signaling pathway | BiologicalProcess |
GO:0045453 | bone resorption | BiologicalProcess |
GO:0035898 | parathyroid hormone secretion | BiologicalProcess |
CL:0000092 | osteoclast | Cell |
GO:0070509 | calcium ion import | BiologicalProcess |
HP:0002901 | Hypocalcemia | PhenotypicFeature |
MESH:D015663 | Postmenopausal osteoporosis | Disease |
Relationships
NOTE: predicates are annotated in Biolink Model (v1.3.0)
Subject | Predicate | Object |
---|---|---|
Ergocalciferol | HAS METABOLITE | 1Α,25-Dihydroxyvitamin D2 |
1Α,25-Dihydroxyvitamin D2 | INCREASES ACTIVITY OF | Vitamin D3 Receptor |
Vitamin D3 Receptor | POSITIVELY REGULATES | Vitamin D Receptor Signaling Pathway |
Vitamin D Receptor Signaling Pathway | POSITIVELY REGULATES | Calcium Ion Import |
Vitamin D Receptor Signaling Pathway | NEGATIVELY REGULATES | Parathyroid Hormone Secretion |
Parathyroid Hormone Secretion | POSITIVELY REGULATES | Osteoclast |
Osteoclast | POSITIVELY CORRELATED WITH | Bone Resorption |
Bone Resorption | POSITIVELY CORRELATED WITH | Postmenopausal Osteoporosis |
Calcium Ion Import | NEGATIVELY CORRELATED WITH | Hypocalcemia |
Hypocalcemia | POSITIVELY CORRELATED WITH | Postmenopausal Osteoporosis |
Reference: